Similar phase I studies evaluating PD-1 directed fusion molecules, including PF-07209960, reported tolerability and pharmacokinetic profiles but left key questions regarding infection surveillance and sustained immune regulation unresolved [135]. Here, PDCD1 is linked to infection.